Tower Research Capital (TRC)’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.66K | Buy |
1,157
+365
| +46% | +$1.15K | ﹤0.01% | 4454 |
|
|
2025
Q1 | $2.8K | Sell |
792
-471
| -37% | -$1.67K | ﹤0.01% | 4504 |
|
|
2024
Q4 | $4.03K | Sell |
1,263
-252
| -17% | -$804 | ﹤0.01% | 4536 |
|
|
2024
Q3 | $5.56K | Buy |
1,515
+176
| +13% | +$646 | ﹤0.01% | 4251 |
|
|
2024
Q2 | $6.25K | Sell |
1,339
-2,017
| -60% | -$9.42K | ﹤0.01% | 4600 |
|
|
2024
Q1 | $29.5K | Buy |
3,356
+2,192
| +188% | +$19.3K | ﹤0.01% | 2665 |
|
|
2023
Q4 | $4.98K | Sell |
1,164
-693
| -37% | -$2.97K | ﹤0.01% | 4891 |
|
|
2023
Q3 | $6.33K | Sell |
1,857
-482
| -21% | -$1.64K | ﹤0.01% | 4612 |
|
|
2023
Q2 | $13.2K | Buy |
2,339
+222
| +10% | +$1.25K | ﹤0.01% | 3773 |
|
|
2023
Q1 | $10K | Buy |
2,117
+2,089
| +7,461% | +$9.87K | ﹤0.01% | 4367 |
|
|
2022
Q4 | $0 | Sell |
28
-3,789
| -99% | – | ﹤0.01% | 6177 |
|
|
2022
Q3 | $19K | Buy |
3,817
+2,690
| +239% | +$13.4K | ﹤0.01% | 3976 |
|
|
2022
Q2 | $6K | Buy |
1,127
+354
| +46% | +$1.89K | ﹤0.01% | 4935 |
|
|
2022
Q1 | $6K | Sell |
773
-839
| -52% | -$6.51K | ﹤0.01% | 4898 |
|
|
2021
Q4 | $13K | Buy |
1,612
+1,082
| +204% | +$8.73K | ﹤0.01% | 4187 |
|
|
2021
Q3 | $6K | Buy |
530
+178
| +51% | +$2.02K | ﹤0.01% | 4762 |
|
|
2021
Q2 | $5K | Buy |
352
+290
| +468% | +$4.12K | ﹤0.01% | 4726 |
|
|
2021
Q1 | $1K | Sell |
62
-531
| -90% | -$8.57K | ﹤0.01% | 5191 |
|
|
2020
Q4 | $11K | Sell |
593
-116
| -16% | -$2.15K | ﹤0.01% | 4249 |
|
|
2020
Q3 | $13K | Buy |
709
+539
| +317% | +$9.88K | ﹤0.01% | 3993 |
|
|
2020
Q2 | $2K | Buy |
+170
| New | +$2K | ﹤0.01% | 4513 |
|